SPY332.11+2.05 0.62%
DIA272.00+3.59 1.34%
IXIC10,998.40+57.23 0.52%

Alexion Pharmaceuticals Q2 Adj. EPS $3.11 Beats $2.59 Estimate, Sales $1.44B Beat $1.28B Estimate

Alexion Pharmaceuticals (NASDAQ:ALXN) reported quarterly earnings of $3.11 per share which beat the analyst consensus estimate of $2.59 by 20.08 percent. This is a 17.8 percent increase over earnings of $2.64 per share

Benzinga · -
Alexion Pharmaceuticals (NASDAQ: ALXN) reported quarterly earnings of $3.11 per share which beat the analyst consensus estimate of $2.59 by 20.08 percent. This is a 17.8 percent increase over earnings of $2.64 per share from the same period last year. The company reported quarterly sales of $1.44 billion which beat the analyst consensus estimate of $1.28 billion by 12.86 percent. This is a 20.08 percent increase over sales of $1.20 billion the same period last year.